Embed Size (px)
Citation preview
State – Equity ConcernState – Equity Concern
««UzpharmsanoatUzpharmsanoat»»
Welcomes guests and participants of Uzbek-U.S.A Welcomes guests and participants of Uzbek-U.S.A Business ForumBusiness Forum
““Investment Opportunities Investment Opportunities ofof the the pharmaceutical industry in the Republic of Uzbekistan pharmaceutical industry in the Republic of Uzbekistan and and prospects of cooperation with the United States of prospects of cooperation with the United States of
America”America” ””
TashkentTashkent 17-18 august 17-18 august 20122012
Structure of pharmaceutical industryStructure of pharmaceutical industry
Enterprises for the production Enterprises for the production of medicines and medicinal of medicines and medicinal
productsproducts (1 (13030))
Scientific institutions and Scientific institutions and scientific research institute on scientific research institute on development and production development and production of substances, organizations of substances, organizations
on training of specialists of the on training of specialists of the high and middle classeshigh and middle classes
Enterprises for the wholesale Enterprises for the wholesale of medicines and medicinal of medicines and medicinal
productsproducts(more than 200)(more than 200)
Drugstores over 8000Drugstores over 8000
33
Ensuring the needs of population on the Ensuring the needs of population on the nomenclature of manufactured nomenclature of manufactured
pharmaceutical productspharmaceutical products, %, %
100 100
5852
47 46
35
20
0
20
40
60
80
100
120
Liquid drug form
s
Bandages
Tablets
Dry powder of a
ntibiotic
Injections
Infusions
Ointments
Vaccines and sera
44
Main goals and aims of SJC Main goals and aims of SJC “Uzpharmsanoat”“Uzpharmsanoat”
Organizations of production of original and Organizations of production of original and generic drugsgeneric drugs;;
Saturation the market’s needs with high Saturation the market’s needs with high quality, export-oriented, accessible drugsquality, export-oriented, accessible drugs;;
Matching national production with Matching national production with international standards quality control ISO, international standards quality control ISO, GMPGMP;;
Organization to attract foreign investmentOrganization to attract foreign investmentto create new productionto create new production socially socially important groups of drugsimportant groups of drugs ;;
Organisation of export of medicinal productsOrganisation of export of medicinal productsand medical productsand medical products
- The volume of pharmaceutical market in 2011 totaled more than 700.0 million USD.
- Share of national producers accounted for 22%
or 150.0 mln USD.
Provision of pharmaceutical market of Provision of pharmaceutical market of UzbekistanUzbekistan
Opportunities for export to bordering Opportunities for export to bordering countriescountries
Knowing the location of Uzbekistan should be noted that the export potential is great as, for example:
Kazakhstan imports annually about 600 million USD;
Tajikistan is approximately 116 million USD;Kyrgyzstan is approximately 100 million USD;Turkmenistan - 140 million USD;Afghanistan - 200 million USD.
The ratio of registered medicines in the Republic of Uzbekistan on 01.01.2012g.
Total - 6236 items
The list of U.S. companies and The list of U.S. companies and Pharmaceutical groups
№Name of U.S. companies
Amount of registered drugs
Pharmaceutical groups
1Ortho-Clinical Diagnostics Inc
1The agent which is mainly applied in obstetrics and gynecology
2 Unipharm Inc 26
Stimulator of a trophicity of tissues and neogenesis, Vitamins, Agent for correction of metabolic processes, Agent for treatment of disturbances of a peripheric circulation, an iodine Preparation, Adaptogen and all-excitant
3
KV Pharmaceuticals Co, Gedeon Richter PLC
США1
Antifungal agent
The list of U.S. companies and The list of U.S. companies and Pharmaceutical groups
№ Name of U.S.companies Amount of registered
drugsPharmaceutical groups
1 Sagmel, Inc. 9The agent applied in the koloproktology, Antifungal agent, Vitamins, Agent for
treatment of diseases of ENT organ.
2Mission Pharmacal
Company1 The agent applied at an urolithiasis
3 Eli Lilly and Company 3 Medicines for Insulin
69
31
Share of foreign partners
Share of national participants
The capital structure of pharmaceutical companies (in mln. USD)
The capital structure of pharmaceutical companies (in mln. USD)
1111
Exempt of VAT and custom dutiesExempt of VAT and custom duties::
Import of raw materials for pharmaceutical Import of raw materials for pharmaceutical productionproduction;;
Technologic equipmentTechnologic equipment;;
Settled technologic equipment is exempt of Settled technologic equipment is exempt of property taxproperty tax for 2 yearsfor 2 years..
Benefits and insensitive for foreign investorsBenefits and insensitive for foreign investors
1212
Together with the company «Merck» arranged market research of pharmaceutical market to identify potential therapeutic areas, with insufficient drug level to supply through local production.
The company «Con Technologies Corporation» has expressed a desire to participate in the project for the production of pharmaceutical products in the SIZ "Angren"
Cooperation with US companies
Total cost of the project of - 28 mln.USD;
Annual production capacity – 1,0 mln conventional units. in a year;
•Payback period – 6 years;
•Profitability – 29 %;
•Created workplaces – 100.
«The organization of production of preparations for treatment of oncologic diseases»
• The proposed location - SIZ "Angren“
• Note: could be changed after consultation with the foreign partner
Total cost of the project of - 25 mln.USD;-
Annual production capacity – 2 mln. packs in a year;
Payback period – 6 years;
Profitability – 27 %;
Created workplaces – 100.
«The organization of production of preparations for treatment of cardiovascular diseases»
• The proposed location - SIZ "Angren“
• Note: could be changed after consultation with the foreign partner
«The organization of production of preparations for treatment of endocrine diseases»
Total cost of the project of-12 mln.USD;
Annual capacity – 5,0 mln. conventional units. in a year;
•Payback period – 5 years;
•Profitability – 20 %;
•Created workplaces – 50.
.• The proposed location - SIZ "Angren“
• Note: could be changed after consultation with the foreign partner
«The organization of production of preparations for treatment of psychoneurological diseases»
Total cost of the project of-30 mln.USD;
Annual capacity – 15,0 mln conventional units. in a year;
•Payback period – 5 years;
•Profitability – 27 %;
•Created workplaces – 50.
.• The proposed location - SIZ "Angren“
• Note: could be changed after consultation with the foreign partner
